[1] |
Shimosegawa T,Chari ST,Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40(3): 352-358.
|
[2] |
Nagpal SJS,Sharma A,Chari ST. Autoimmune pancreatitis[J]. Am J Gastroenterol, 2018, 113(9):1301-1309.
|
[3] |
Toomey DP,Swan N,Torreggiani W, et al. Autoimmune pancreatitis[J]. Br J Surg, 2007, 94(9):1067-1074.
|
[4] |
Negrelli R,Boninsegna E,Avesani G, et al. Type 1 and type 2 autoimmune pancreatitis: distinctive clinical and pathological features, but are there any differences at magnetic resonance? experience from a referral center[J]. Pancreas, 2018, 47(9):1115-1122.
|
[5] |
Okazaki K,Uchida K. Current concept of autoimmune pancreatitis and IgG4-related disease[J]. Am J Gastroenterol, 2018, 113(10):1412-1416.
|
[6] |
Kamisawa T,Takuma K,Egawa N, et al. Autoimmune pancreatitis and IgG4-related sclerosing disease[J]. Nat Rev Gastroenterol Hepatol, 2010, 7(7):401-409.
|
[7] |
Takuma K,Kamisawa T,Gopalakrishna R, et al. Strategy to differentiate autoimmune pancreatitis from pancreas cancer[J]. World J Gastroenterol, 2012, 18(10):1015-1020.
|
[8] |
Tempero MA,Uchida E,Takasaki H, et al. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer[J]. Cancer Res, 1987, 47(20):5501-5503.
|
[9] |
van Heerde MJ,Buijs J,Hansen BE, et al. Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma[J]. Dig Dis Sci, 2014, 59(6):1322-1329.
|
[10] |
Kamisawa T,Takuma K,Anjiki H, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI[J]. Am J Gastroenterol, 2010, 105(8): 1870-1875.
|
[11] |
Kawa S,Okazaki K,Kamisawa T, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 II. extrapancreatic lesions, differential diagnosis[J]. J Gastroenterol, 2014, 49(5):765-784.
|
[12] |
Dimastromatteo J,Brentnall T,Kelly KA. Imaging in pancreatic disease[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(2):97-109.
|
[13] |
Cho MK,Moon SH,Song TJ, et al. Contrast-enhanced endoscopic ultrasound for differentially diagnosing autoimmune pancreatitis and pancreatic cancer[J]. Gut Liver, 2018, 12(5):591-596.
|
[14] |
Bhattacharya A,Cruise M,Chahal P. Endoscopic ultrasound guided 22 gauge core needle biopsy for the diagnosis of autoimmune pancreatitis[J]. Pancreatology, 2018, 18(2):168-169.
|
[15] |
Iglesias-Garcia J,Larino-Noia J,Abdulkader I, et al. Quantitative endoscopic ultrasound elastography: an accurate method for the differentiation of solid pancreatic masses[J]. Gastroenterology, 2010, 139(4):1172-1180.
|
[16] |
Iglesias-Garcia J,Domínguez-Muñoz JE,Castiñeira-Alvariño M, et al. Quantitative elastography associated with endoscopic ultrasound for the diagnosis of chronic pancreatitis[J]. Endoscopy, 2013, 45(10): 781-788.
|
[17] |
Kamisawa T,Takum K,Anjiki H, et al. FDG-PET/CT findings of autoimmune pancreatitis[J]. Hepatogastroenterology, 2010, 57(99/100):447-450.
|
[18] |
Zhang J,Jia G,Zuo C, et al. 18F-FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer[J]. BMC Cancer, 2017, 17(1):695.
|
[19] |
张太平,冯梦宇,曹喆,等.胰腺囊性肿瘤诊断进展及评价[J].中国实用外科杂志,2018, 38(7):749-753.
|
[20] |
张太平,邱江东,冯梦宇,等.偶发无功能胰腺神经内分泌肿瘤的治疗进展与争议[J].中华消化外科杂志,2018, 17(7):666-670.
|